5-Methyl-2-pyrrolidone → 1-{4-[4-(2,4-Dimethylphenyl)piperazine-1-carbonyl]phenyl}-5-methylpyrrolidin-2-one

HRID 2411732Notes

Reaction equation

HRID 2411732 reaction equation
Br[C:2]1[CH:7]=[CH:6][C:5]([C:8]([N:10]2[CH2:15][CH2:14][N:13]([C:16]3[CH:21]=[CH:20][C:19]([CH3:22])=[CH:18][C:17]=3[CH3:23])[CH2:12][CH2:11]2)=[O:9])=[CH:4][CH:3]=1.[CH3:24][CH:25]1[NH:29][C:28](=[O:30])[CH2:27][CH2:26]1>>[CH3:23][C:17]1[CH:18]=[C:19]([CH3:22])[CH:20]=[CH:21][C:16]=1[N:13]1[CH2:14][CH2:15][N:10]([C:8]([C:5]2[CH:6]=[CH:7][C:2]([N:29]3[CH:25]([CH3:24])[CH2:26][CH2:27][C:28]3=[O:30])=[CH:3][CH:4]=2)=[O:9])[CH2:11][CH2:12]1

Participants

3

Procedure

Using (4-bromophenyl)[4-(2,4-dimethylphenyl)piperazin-1-yl]methanone (747 mg) described in Preparation Example 170 and 5-methylpyrrolidin-2-one (198 mg) and by the reaction and treatment in the same manner as in Example 1, the title compound (367 mg) was obtained.

Sources & evidence

ORD record
ord-3722a3c7ba214db4b48f53331f96b901
Source dataset
uspto-grants-2014_08
Patent number
US08816079B2

Reaction notes

Loading…